Climb Bio, Inc. (CLYM) Form SCHEDULE 13D/A — Jul 7, 2026
RA Capital Management, L.P., along with its affiliated funds and Peter Kolchinsky, has filed a Joint Filing Agreement to facilitate the joint filing of a Schedule 13D and/or 13G regarding their ownership of Climb Bio, Inc. This agreement allows the investment group to file a single consolidated statement on behalf of all parties, as permitted by Rule 13(d)(1)(k) of the Securities Exchange Act of 1934.
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.